PAVM logo

PAVM
PAVmed Inc

9,224
Mkt Cap
$45.75M
Volume
6,475.00
52W High
$28.44
52W Low
$6.00
PE Ratio
-0.17
PAVM Fundamentals
Price
$6.39
Prev Close
$6.35
Open
$6.20
50D MA
$8.63
Beta
1.13
Avg. Volume
12,784.71
EPS (Annual)
-$5.63
P/B
1.12
Rev/Employee
$1,731.71
$29.26
Loading...
Loading...
News
all
press releases
PAVmed (PAVM) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
More News
News Placeholder
PAVmed (PAVM) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
PAVmed (PAVM) delivered earnings and revenue surprises of -69.57% and -78.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW YORK, May 15, 2026...
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -40.00% and -10.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW...
News Placeholder
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
NeuroPace (NPCE) delivered earnings and revenue surprises of +32.75% and +2.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Steris (STE) delivered earnings and revenue surprises of -0.88% and -0.47%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
PAVmed (PAVM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available